CELUW
Celularity Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.03 |
| Day High | $0.01 |
| Day Low | $0.00 |
| Volume | 350 |
Stock Information
| Total Debt | $74.71M |
| Cash Equivalents | $6.17M |
| Revenue | $26.55M |
| Net Income | $-91.80M |
| EPS (TTM) | $-0.87 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $26.55M |
| Income | $-91.80M |
| Book/sh | $-1.32 |
| Employees | 115 |
Financial Ratios
| Quick Ratio | 0.14 |
| Current Ratio | 0.15 |
Returns & Margins
| ROA | -30.93% |
| Gross Margin | 24.39% |
| Operating Margin | -492.15% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | -0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| RSI | nan |
| Shares Float | 18.87M |
| Volatility | 0.48 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| YTD | +2.96% |
| 10 Years | +2.96% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-12 | $0.01 | 0 |
| 2026-06-11 | $0.01 | 0 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 0 |
| 2026-06-08 | $0.01 | 0 |
| 2026-06-05 | $0.01 | 0 |
| 2026-06-04 | $0.01 | 0 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 0 |
| 2026-06-01 | $0.01 | 0 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 0 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 0 |
| 2026-05-22 | $0.01 | 0 |
| 2026-05-21 | $0.01 | 0 |
| 2026-05-20 | $0.01 | 0 |
| 2026-05-19 | $0.01 | 0 |
About Celularity Inc.
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
đ° Latest News
NEXGEL, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-04-21T12:30:00Z
Celularity Second Quarter 2025 Earnings: US$1.02 loss per share (vs US$0.30 loss in 2Q 2024)
Simply Wall St. âĸ 2025-08-31T12:47:37Z
Retail investors among Celularity Inc.'s (NASDAQ:CELU) largest shareholders, saw gain in holdings value after stock jumped 11% last week
Simply Wall St. âĸ 2025-08-14T10:32:14Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $14,272,000 | $8,820,000 | $8,885,000 | $12,422,000 |
| Cost Of Revenue | $20,074,000 | $14,989,000 | $16,016,000 | $19,665,000 |
| Total Revenue | $26,550,000 | $54,220,000 | $22,771,000 | $17,975,000 |
| Operating Revenue | $26,550,000 | $54,220,000 | $22,771,000 | $17,975,000 |
| Expenses | ||||
| Interest Expense | $6,754,000 | $6,264,000 | $3,015,000 | $0 |
| Total Expenses | $87,858,000 | $92,771,000 | $99,250,000 | $166,242,000 |
| Other Income Expense | $-23,913,000 | $-13,408,000 | $-117,111,000 | $162,107,000 |
| Other Non Operating Income Expenses | $-11,414,000 | $-10,091,000 | $-7,467,000 | $-2,669,000 |
| Net Non Operating Interest Income Expense | $-6,492,000 | $-5,933,000 | $-2,695,000 | $365,000 |
| Interest Expense Non Operating | $6,754,000 | $6,264,000 | $3,015,000 | $0 |
| Operating Expense | $67,784,000 | $77,782,000 | $83,234,000 | $146,577,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-91,716,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Net Interest Income | $-6,492,000 | $-5,933,000 | $-2,695,000 | $365,000 |
| Interest Income | $262,000 | $331,000 | $320,000 | $365,000 |
| Normalized Income | $-81,841,790 | $-54,575,000 | $-86,651,000 | $-150,584,000 |
| Net Income From Continuing And Discontinued Operation | $-91,716,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Total Operating Income As Reported | $-61,308,000 | $-38,358,000 | $-192,287,000 | $-25,600,000 |
| Net Income Common Stockholders | $-91,800,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Net Income | $-91,716,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Net Income Including Noncontrolling Interests | $-91,716,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Net Income Continuous Operations | $-91,716,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Pretax Income | $-91,713,000 | $-57,892,000 | $-196,285,000 | $14,205,000 |
| Special Income Charges | $-9,246,000 | $-3,715,000 | $-115,808,000 | $122,667,000 |
| Interest Income Non Operating | $262,000 | $331,000 | $320,000 | $365,000 |
| Operating Income | $-61,308,000 | $-38,551,000 | $-76,479,000 | $-148,267,000 |
| Depreciation Amortization Depletion Income Statement | $1,493,000 | $1,753,000 | $2,193,000 | $2,193,000 |
| Depreciation And Amortization In Income Statement | $1,493,000 | $1,753,000 | $2,193,000 | $2,193,000 |
| Amortization Of Intangibles Income Statement | $1,493,000 | $1,753,000 | $2,193,000 | $2,193,000 |
| Gross Profit | $6,476,000 | $39,231,000 | $6,755,000 | $-1,690,000 |
| Other | ||||
| Tax Effect Of Unusual Items | $-2,624,790 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-65,165,000 | $-40,389,000 | $-74,302,000 | $-141,135,000 |
| Total Unusual Items | $-12,499,000 | $-3,317,000 | $-109,644,000 | $164,776,000 |
| Total Unusual Items Excluding Goodwill | $-12,499,000 | $-3,317,000 | $-109,644,000 | $164,776,000 |
| Reconciled Depreciation | $7,295,000 | $7,922,000 | $9,324,000 | $9,436,000 |
| EBITDA (Bullshit earnings) | $-77,664,000 | $-43,706,000 | $-183,946,000 | $23,641,000 |
| EBIT | $-84,959,000 | $-51,628,000 | $-193,270,000 | $14,205,000 |
| Diluted NI Availto Com Stockholders | $-91,800,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Otherunder Preferred Stock Dividend | $64,000 | $0 | - | - |
| Preferred Stock Dividends | $20,000 | - | - | - |
| Tax Provision | $3,000 | $0 | $10,000 | $13,000 |
| Other Special Charges | $6,356,000 | $3,908,000 | - | - |
| Write Off | $2,890,000 | $0 | $107,800,000 | $0 |
| Restructuring And Mergern Acquisition | $0 | $-193,000 | $-104,339,000 | $-126,277,000 |
| Gain On Sale Of Security | $-3,253,000 | $398,000 | $6,164,000 | $42,109,000 |
| Amortization | $1,493,000 | $1,753,000 | $2,193,000 | $2,193,000 |
| Research And Development | $15,025,000 | $17,386,000 | $30,465,000 | $78,363,000 |
| Selling General And Administration | $51,266,000 | $58,643,000 | $50,576,000 | $66,021,000 |
| Impairment Of Capital Assets | - | $0 | $112,347,000 | $3,610,000 |
| Gain On Sale Of Business | - | - | - | - |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-53,165,000 | $-7,758,000 | $22,612,000 | $-41,787,000 |
| Total Assets | $107,329,000 | $132,682,000 | $143,889,000 | $401,066,000 |
| Total Non Current Assets | $95,010,000 | $112,121,000 | $124,096,000 | $367,564,000 |
| Other Non Current Assets | $13,390,000 | $23,096,000 | $26,930,000 | $38,161,000 |
| Goodwill And Other Intangible Assets | $15,103,000 | $16,595,000 | $18,348,000 | $240,688,000 |
| Other Intangible Assets | $7,756,000 | $9,248,000 | $11,001,000 | $120,994,000 |
| Current Assets | $12,319,000 | $20,561,000 | $19,793,000 | $33,502,000 |
| Other Current Assets | $222,000 | $261,000 | $329,000 | $1,049,000 |
| Prepaid Assets | $698,000 | $596,000 | $1,366,000 | $6,213,000 |
| Inventory | $571,000 | $5,409,000 | $5,753,000 | $5,308,000 |
| Receivables | $4,653,000 | $13,557,000 | $12,118,000 | $6,966,000 |
| Accounts Receivable | $4,653,000 | $13,557,000 | $10,046,000 | $4,452,000 |
| Allowance For Doubtful Accounts Receivable | $-7,647,000 | $-6,294,000 | $-5,837,000 | $-1,789,000 |
| Gross Accounts Receivable | $12,300,000 | $19,851,000 | $15,883,000 | $6,241,000 |
| Cash Cash Equivalents And Short Term Investments | $6,175,000 | $738,000 | $227,000 | $13,966,000 |
| Cash And Cash Equivalents | $6,175,000 | $738,000 | $227,000 | $13,966,000 |
| Notes Receivable | - | $0 | $2,072,000 | $2,514,000 |
| Debt | ||||
| Net Debt | $7,828,000 | $41,550,000 | $39,013,000 | $23,637,000 |
| Total Debt | $40,901,000 | $68,836,000 | $65,417,000 | $65,588,000 |
| Long Term Debt And Capital Lease Obligation | $26,898,000 | $62,475,000 | $26,177,000 | $27,985,000 |
| Current Debt And Capital Lease Obligation | $14,003,000 | $6,361,000 | $39,240,000 | $37,603,000 |
| Current Debt | $14,003,000 | $6,361,000 | $39,240,000 | $37,603,000 |
| Other Current Borrowings | $7,127,000 | $6,361,000 | $39,240,000 | $37,603,000 |
| Long Term Debt | - | $35,927,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $145,391,000 | $123,845,000 | $102,929,000 | $202,165,000 |
| Total Non Current Liabilities Net Minority Interest | $64,632,000 | $70,165,000 | $35,631,000 | $140,077,000 |
| Other Non Current Liabilities | $33,378,000 | $1,693,000 | $1,900,000 | $106,266,000 |
| Derivative Product Liabilities | $1,545,000 | $3,264,000 | $4,359,000 | $3,598,000 |
| Non Current Deferred Liabilities | $2,811,000 | $2,733,000 | $3,195,000 | $2,228,000 |
| Non Current Deferred Taxes Liabilities | $12,000 | $9,000 | $9,000 | $9,000 |
| Current Liabilities | $80,759,000 | $53,680,000 | $67,298,000 | $62,088,000 |
| Other Current Liabilities | $6,925,000 | $1,090,000 | $2,448,000 | $2,632,000 |
| Current Deferred Liabilities | $5,255,000 | $3,531,000 | $2,834,000 | $2,273,000 |
| Current Notes Payable | $6,876,000 | - | - | - |
| Payables And Accrued Expenses | $54,576,000 | $42,698,000 | $22,776,000 | $19,580,000 |
| Interest Payable | $0 | $1,798,000 | $0 | - |
| Payables | $26,422,000 | $23,296,000 | $14,144,000 | $5,810,000 |
| Accounts Payable | $26,422,000 | $23,296,000 | $14,144,000 | $5,810,000 |
| Equity | ||||
| Common Stock Equity | $-38,062,000 | $8,837,000 | $40,960,000 | $198,901,000 |
| Total Equity Gross Minority Interest | $-38,062,000 | $8,837,000 | $40,960,000 | $198,901,000 |
| Stockholders Equity | $-38,062,000 | $8,837,000 | $40,960,000 | $198,901,000 |
| Gains Losses Not Affecting Retained Earnings | $0 | $-5,000 | $0 | $9,000 |
| Retained Earnings | $-991,483,000 | $-899,683,000 | $-841,791,000 | $-645,496,000 |
| Other Equity Adjustments | - | $-5,000 | - | $9,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $28,837,787 | $22,546,671 | $19,378,164 | $14,892,118 |
| Share Issued | $28,837,787 | $22,546,671 | $19,378,164 | $14,892,118 |
| Tangible Book Value | $-53,165,000 | $-7,758,000 | $22,612,000 | $-41,787,000 |
| Invested Capital | $-24,059,000 | $51,125,000 | $80,200,000 | $236,504,000 |
| Working Capital | $-68,440,000 | $-33,119,000 | $-47,505,000 | $-28,586,000 |
| Capital Lease Obligations | $26,898,000 | $26,548,000 | $26,177,000 | $27,985,000 |
| Total Capitalization | $-38,062,000 | $44,764,000 | $40,960,000 | $198,901,000 |
| Additional Paid In Capital | $953,418,000 | $908,523,000 | $882,732,000 | $844,373,000 |
| Capital Stock | $3,000 | $2,000 | $19,000 | $15,000 |
| Common Stock | $3,000 | $2,000 | $19,000 | $15,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $2,799,000 | $2,724,000 | $3,186,000 | $2,219,000 |
| Long Term Capital Lease Obligation | $26,898,000 | $26,548,000 | $26,177,000 | $27,985,000 |
| Current Deferred Revenue | $5,255,000 | $3,531,000 | $2,834,000 | $2,273,000 |
| Current Accrued Expenses | $28,154,000 | $19,402,000 | $8,632,000 | $13,770,000 |
| Goodwill | $7,347,000 | $7,347,000 | $7,347,000 | $119,694,000 |
| Net PPE | $66,517,000 | $72,430,000 | $78,818,000 | $88,715,000 |
| Accumulated Depreciation | $-38,670,000 | $-32,867,000 | $-27,278,000 | $-20,331,000 |
| Gross PPE | $105,187,000 | $105,297,000 | $106,096,000 | $109,046,000 |
| Leases | $73,211,000 | $73,211,000 | $73,211,000 | $70,113,000 |
| Other Properties | $24,813,000 | $24,923,000 | $25,083,000 | $27,493,000 |
| Machinery Furniture Equipment | $7,163,000 | $7,163,000 | $7,781,000 | $7,780,000 |
| Properties | $0 | $0 | $0 | $0 |
| Construction In Progress | - | $0 | $21,000 | $3,660,000 |
| Treasury Shares Number | - | - | $0 | - |
| Current Capital Lease Obligation | - | - | - | $0 |
| Buildings And Improvements | - | - | - | $0 |
| Treasury Stock | - | - | - | - |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-13,254,000 | $-6,562,000 | $-42,733,000 | $-143,112,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-13,254,000 | $-6,401,000 | $-38,685,000 | $-137,876,000 |
| Cash Flow From Continuing Operating Activities | $-13,257,000 | $-6,401,000 | $-38,685,000 | $-137,876,000 |
| Operating Gains Losses | $9,609,000 | $3,510,000 | $-5,761,000 | $-42,109,000 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $514,000 | $-4,048,000 | $-5,236,000 |
| Cash Flow From Continuing Investing Activities | $0 | $514,000 | $-4,048,000 | $-5,236,000 |
| Capital Expenditure Reported | $0 | $-161,000 | $-1,048,000 | $-5,236,000 |
| Capital Expenditure | - | $-161,000 | $-4,048,000 | $-5,236,000 |
| Net Other Investing Changes | - | $2,175,000 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,000,000 | $6,000,000 | $21,886,000 | $36,519,000 |
| Financing Cash Flow | $18,649,000 | $6,701,000 | $24,094,000 | $119,838,000 |
| Cash Flow From Continuing Financing Activities | $18,649,000 | $6,701,000 | $24,094,000 | $119,838,000 |
| Net Other Financing Charges | $255,000 | $-459,000 | $-1,654,000 | $-3,234,000 |
| Cash Dividends Paid | $-5,900,000 | $0 | - | - |
| Net Common Stock Issuance | $4,000,000 | $6,000,000 | $21,886,000 | $36,519,000 |
| Common Stock Issuance | $4,000,000 | $6,000,000 | $21,886,000 | $36,519,000 |
| Repurchase Of Capital Stock | - | - | - | - |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-121,000 | $-17,520,000 | $-16,811,000 | $0 |
| Issuance Of Debt | $0 | $3,622,000 | $2,000,000 | $85,691,000 |
| Interest Paid Supplemental Data | $2,502,000 | $144,000 | $1,073,000 | $0 |
| Income Tax Paid Supplemental Data | $52,000 | $0 | - | $0 |
| End Cash Position | $16,372,000 | $10,977,000 | $10,163,000 | $28,802,000 |
| Beginning Cash Position | $10,977,000 | $10,163,000 | $28,802,000 | $52,076,000 |
| Changes In Cash | $5,395,000 | $814,000 | $-18,639,000 | $-23,274,000 |
| Proceeds From Stock Option Exercised | $20,415,000 | $15,058,000 | $18,673,000 | $862,000 |
| Net Issuance Payments Of Debt | $-121,000 | $-13,898,000 | $-14,811,000 | $85,691,000 |
| Net Short Term Debt Issuance | $-121,000 | $-13,898,000 | $-14,811,000 | $39,200,000 |
| Short Term Debt Payments | $-121,000 | $-17,520,000 | $-16,811,000 | $0 |
| Short Term Debt Issuance | $0 | $3,622,000 | $2,000,000 | $39,200,000 |
| Net Business Purchase And Sale | $0 | $-1,500,000 | $0 | - |
| Purchase Of Business | $0 | $-1,500,000 | $0 | - |
| Change In Working Capital | $33,594,000 | $22,200,000 | $3,252,000 | $-17,976,000 |
| Change In Other Working Capital | $-741,000 | $606,000 | $1,803,000 | $688,000 |
| Change In Payables And Accrued Expense | $16,578,000 | $18,373,000 | $3,535,000 | $1,762,000 |
| Change In Accrued Expense | $13,452,000 | $9,134,000 | $-4,962,000 | $4,710,000 |
| Change In Payable | $3,126,000 | $9,239,000 | $8,497,000 | $-2,948,000 |
| Change In Account Payable | $3,126,000 | $9,239,000 | $8,497,000 | $-2,948,000 |
| Change In Prepaid Assets | $-40,000 | $905,000 | $5,606,000 | $49,000 |
| Change In Inventory | $10,246,000 | $6,284,000 | $-865,000 | $-16,891,000 |
| Change In Receivables | $7,551,000 | $-3,968,000 | $-6,827,000 | $-3,584,000 |
| Changes In Account Receivables | $7,551,000 | $-3,968,000 | $-6,827,000 | $-3,584,000 |
| Other Non Cash Items | $9,110,000 | $5,553,000 | $-92,314,000 | $-123,665,000 |
| Stock Based Compensation | $10,378,000 | $11,569,000 | $15,017,000 | $15,856,000 |
| Provisionand Write Offof Assets | $1,251,000 | $271,000 | $2,561,000 | $1,877,000 |
| Asset Impairment Charge | $7,225,000 | $466,000 | $225,531,000 | $4,514,000 |
| Depreciation Amortization Depletion | $7,295,000 | $7,922,000 | $9,324,000 | $9,436,000 |
| Depreciation And Amortization | $7,295,000 | $7,922,000 | $9,324,000 | $9,436,000 |
| Amortization Cash Flow | $1,492,000 | $1,753,000 | $2,193,000 | - |
| Amortization Of Intangibles | $1,492,000 | $1,753,000 | $2,193,000 | - |
| Depreciation | $5,803,000 | $6,169,000 | $7,131,000 | - |
| Gain Loss On Investment Securities | $3,253,000 | $-398,000 | $-5,761,000 | $-42,109,000 |
| Net Income From Continuing Operations | $-91,716,000 | $-57,892,000 | $-196,295,000 | $14,192,000 |
| Net Intangibles Purchase And Sale | - | $0 | $-3,000,000 | $0 |
| Purchase Of Intangibles | - | $0 | $-3,000,000 | $0 |
| Net Long Term Debt Issuance | - | - | $17,369,000 | $46,491,000 |
| Long Term Debt Issuance | - | - | $17,369,000 | $46,491,000 |
| Deferred Tax | - | - | $0 | $-1,000 |
| Deferred Income Tax | - | - | $0 | $-1,000 |
| Common Stock Payments | - | - | - | - |
| Sale Of Business | - | - | - | - |
| Gain Loss On Sale Of Business | - | - | - | - |
Fetched: 2026-06-16